Age-related diseases, including age-related macular degeneration (AMD), are of growing
importance in a world where population ageing has become a dominant global trend …

Over a third of older adults in the US experience significant vision loss, which decreases
independence and is a biomarker of decreased health span. As the global aging population …

Age-related macular degeneration (AMD) is a leading cause of blindness. Late AMD can be
classified into exudative (commonly known as wet AMD [wAMD]) or dry AMD, both of which …

The retinal pigment epithelium (RPE) is the primary site of injury in non-neovascular age-
related macular degeneration or dry AMD. Polymorphisms in genes that regulate …

Background/aims To investigate the association of commonly used systemic medications
with prevalent age-related macular degeneration (AMD) in the general population. Methods …

Obesity is known to be associated with numerous ocular manifestations, including but not
limited to, diabetic retinopathy (DR), age‐related macular degeneration (AMD), cataracts …

Age-related Macular Degeneration (AMD) is a major cause of irreversible vision loss in
individuals over 55 years old in the United States. One of the late-stage manifestations of …

There is increasing consensus in considering statins beneficial for age-related macular
degeneration and in general, for immune and inflammatory mediated diseases affecting the …

Age-related macular degeneration (AMD) is a progressive chronic disease causing visual
impairment or central vision loss in the elderly. We hypothesized that successful …

Summary Dansk Resumé (Danish summary) Aldersrelateret makuladegeneration (AMD) er
den hyppigste årsag til uopretteligt synstab og blindhed i højindkomstlande. Det er en …